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Introduction
Four-strand hamstring tendons or bone-patellar tendon-
bone are the most commonly used autograft and actually
represent the gold standard for the anterior cruciate liga-
ment (ACL) reconstruction.1,2 The main complications
reported with the use of tendon autografts are related to
graft harvesting and donor site morbidity.3
Synthetic grafts have been proposed to overcome the
problems related to the use of autografts. The ﬁrst attempt
to use an artiﬁcial ligament for ACL reconstructionwasmade
in 1918 by Smith, who proposed a graft made up of multiple
silk sutures fastened with staples.4 Unfortunately, the pro-
cedure was unsuccessful with a complete graft failure within
the ﬁrst 3 months from the implantation.
Between 1970s and 1980s, there was a progressive new
interest in the use of artiﬁcial ligaments, supported by the
development of new materials and new devices such as
Teﬂon, carbon ﬁbers, Gore-Tex, Dacron, and subsequently
Leeds-Keio and Kennedy-ligament augmentation device
(LAD). During the years, these materials have all been
abandoned due to the high rate of complications related
with their use, like reactive synovitis and graft breakage in
short or medium term, and in the 1990s the use of synthetic
grafts was completely abandoned.5–8
In the last years of 1990s, a new generation of synthetic
graft for ligament reconstruction has been proposed, with
the introduction of the Ligament Advanced Reinforcement
System (LARS; LARS Company, Arc sur Tille, France). Despite
being introduced in the market since several years ago, it is
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Abstract Purpose The aim of this retrospective study was to evaluate the subjective and
functional outcome of anterior cruciate ligament (ACL) reconstruction with the
synthetic Ligament Advanced Reinforcement System (LARS) ligament.
Methods Twenty-six patients were reviewed at an average follow-up of 11.6 years.
Objective clinical evaluationwas performedwith stability tests. Patient-reported outcomes
(Visual Analogue Scale, Knee Injury andOsteoarthritis Outcome Score, and Cincinnati Knee
Rating Scale) were used to assess subjective and functional outcomes.
Results Overall satisfactory results were obtained in 22 cases (84.6%). Four patients
(15.4%) showed mechanical failure of the graft. No cases of synovitis or infection were
reported.
Conclusion LARS ligament can be considered a safe and suitable option for ACL
reconstruction in carefully selected cases, especially elderly patients needing a rapid
postoperative recovery.
Level of Evidence Level IV, retrospective case series.
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not widely used yet.9 This is probably due to the small
number of long-term studies and the negative previous
experiences with the last generation of synthetic ligaments.
The aim of this study was to evaluate the safety and the
efﬁcacy of ACL reconstruction with the LARS ligament at
long-term follow-up. The hypothesis of the study was that
ACL reconstructionwith the LARS artiﬁcial ligament is a safe
and effective procedure.
Methods
Participants
This study was designed as a retrospective analysis of
patients who have undergone primary, isolated ACL recon-
struction using the LARS ligament in a single institution
between 2003 and 2005. The study was authorized by the
internal revision board and was performed in accordance
with the ethical standards of the 1964Declaration of Helsinki
as revised in 2000.
The use of a synthetic graft for the ACL reconstructionwas
proposed to all patients older than 30 years with a sympto-
matic isolated ACL injury that required a quick return to their
previous sport activity level as a possible alternative to the
autograft. All patients were clearly informed about the
advantages and the possible complications related to the
use of a synthetic graft.
All patients gave informed consent before being included
into the study.
Interventions
All the procedures were performed under regional anesthe-
sia by the same surgeon. In all cases, the ACL reconstruction
was performed with an arthroscopically assisted technique.
Two types of LARS ligament were used: the AC50DB with a
strength of 2,300 Newton and a diameter of 5 mm and the
AC40DB with a strength of 1,700 Newton and a diameter of
4 mm. The choice between these two types of LARS was
related mainly to the patients’ weight (we used the AC50DB
for patients weighing more than 80 kg).
The LARS ligament was placed into the native femoral and
tibial ACL footprint. The tibial tunnel was created using a
cannulated reamer matching the diameter of the graft
(7.5 mm for the AC40DB and 8 mm for the AC50DB). The
tibial guide was angled at 55° to the tibial plateau. The
femoral reamer was, then, introduced through the tibial
tunnel at 90° of knee ﬂexion, and the half femoral tunnel
was reamed under arthroscopic control reaching a depth of
35 to 40 mm. The doubled LARS ligament was then intro-
duced and ﬁxed to the femur using a suspensory crosspin
ﬁxation device (Transﬁx; Arthrex, Naples, Florida, United
States) and to the tibia using a metal interference screw.
Postoperative rehabilitation started from the ﬁrst post-
operative day by performing active and passive knee range
of motion (ROM) exercises. Patients were discharged on
the second postoperative day and partial weight-bearing on
the operated limb was allowed for 2 weeks. After that period,
patients were progressively allowed to increase the weight-
bearing reaching thefullweight-bearing4weeksafter surgery.
Outcome Measures
All the patients were clinically evaluated for pain, swelling,
stability, and ROM. Knee stability was tested using the Roli-
meter knee tester (Aircast; DJOGlobal, Vista, California, United
States)10 for the anterior drawer test and the Lachman test.
Both tests were performed three times on both knees and the
average side-to-side (SSD) difference at maximal manual
traction was recorded. Instrumental evaluation of anterior
knee stability was scored as excellent (SSD < 2 mm), good
(SSD ¼ 2–4 mm), or poor (SSD > 4 mm).
Subjective and functional evaluation was based on three
patient-reported outcomes (PROs): the Visual Analogue
Scale (VAS), the Knee Injury and Osteoarthritis Outcome
Score (KOOS), and the Cincinnati knee rating scales.
The VAS is used to quantify the pain perceived by the
patient on the affected limb.
The KOOS is a PROmeasurement instrument, developed to
assess the patients’ opinion about their knee and associated
problems. The KOOS evaluates both short-term and long-term
consequences of knee injury includingACL ligament injuries. It
holds 42 items in 5 separately scored subscales: pain, symp-
toms, function in daily living (KOOS-ADL), function in sport
and recreation (KOOS-Sport/Rec), and knee-related quality of
life (KOOS-QOL).11
The Cincinnati knee rating scales evaluates eight subjec-
tive parameters (pain, swelling, giving way, overall activity
level, walking, stairs, running, jumping, or twisting) to assess
the patient’s functional recovery.12
Results
From January 2003 to December 2005, we performed 29 ACL
reconstructions using the LARS ligament. The mean age of
patients was 38.5 years (range, 32–52 years). Gender dis-
tributionwas 20males and 6 females. Average time between
injury and surgery was 2 months (range, 1–5 months). All
patients returned to sports activities after an average of
4 months (range, 1.5–7 months).
Three patients were lost at the follow-up, but we were
unable to establish the reasons for their loss, because we
could not contact them. The remaining 26 patients were
examined at an average follow-up of 139.3 months (range,
129–154 months).
We recorded four cases of mechanical graft failure that
occurred after a new sports injury. In one case, it occurred
after 4 years from the implantation and in three cases over
10 years after surgery (►Fig. 1). All the cases of LARS failure
were documented by a magnetic resonance imaging (MRI)
evaluation. Only two cases required a surgical revision for a
persistent knee instability. The torn graft was removed
arthroscopically and replaced with a new LARS ligament
using the same surgical technique. In the other two cases, the
MRI showed graft breakage, but the patients did not suffer
from knee instability.
Clinical assessment did not reveal signs of graft-related
problems like knee reactive synovitis. Absence of reactive
knee synovitis was also conﬁrmed by MRI evaluations that
were available at follow-up in 15 patients.
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ROM of the treated knee did not differ from the contral-
ateral one in 15 patients (57.7%). Loss of knee ﬂexion of less
than 10° was observed in 7 patients (26.9%) and between 10°
and 15° in 4 patients (15.4%).
Instrumented analysis of anterior knee laxity with
the Rolimeter knee tester showed an excellent result (SSD
< 2 mm) in 15 patients (57.7%), good (SSD ¼ 2–4 mm) in 7
cases (26.9%), and poor (SSD > 4 mm) in 4 cases (15.4%).
The mean VAS was 1.69. Score distribution was 0 to 2
points in 17 patients (65.4%), 3 to 5 points in 6 patients
(23.1%), and 6 to 8 points in 3 patients (11.5%).
Global mean KOOSwas 80 with 13 (50%) excellent results,
9 good results (34.6%), and 4 poor result (15.4%) (►Table 1).
Functional evaluation with the Cincinnati knee rating
scale showed a mean score of 84.5 points (range, 53–100
points) with 15 excellent results (57.7%), 7 good results
(26.9%), and 4 poor results (15.4%).
Discussion
Artiﬁcial substitutes of ACL gained popularity in the 1970s
and 1980s, but the high failure rate (reactive synovitis and
mechanical breakdown) led to a complete stop in their use in
the 1990s.13 During the past 15 years, the development of
biocompatible materials and a better understanding of the
knee kinematics led to the development of a new generation
of synthetic grafts.9
The LARS ligament consists of ﬁbersmade of polyethylene
terephthalate (PET) composed of two parts: an intraosseous
segment composed of longitudinal ﬁbers bound together by
a transverse knitted structure and an intra-articular segment
composed of parallel longitudinal free ﬁbers twisted at 90°.
The PET ﬁbers of the intra-articular segment are designed to
encourage tissue ingrowth due to the porosity of the mate-
rial, allowing ingrowth from the surrounding bony tunnels as
shown from in vitro studies.14
Table 1 KOOS results
Mean value
(range)
Excellent
> 90
N (%)
Good
70–89
N (%)
Poor
< 69
N (%)
Symptoms 83 (35–100) 14 (53.8) 8 (30.8) 4 (15.4)
Pain 89 (66–100) 16 (61.5) 8 (30.8) 2 (7.7)
Function
daily living
83 (59–100) 16 (61.5) 6 (23.1) 4 (15.4)
Sport/
recreation
function
82 (45–100) 13 (50) 7 (26.9) 6 (23.1)
Quality
of life
77 (18–100) 10 (38.4) 8 (30.8) 8 (30.8)
Global 80 (53–100) 13 (50) 9 (34.6) 4 (15.4)
Abbreviation: KOOS, Knee Injury and Osteoarthritis Outcome Score.
Fig. 1 Mechanical graft failure occurred at 4 years in a 38-year-old man during sport activity (soccer). (A, B) Magnetic resonance imaging (MRI)
evaluation showed Ligament Advanced Reinforcement System (LARS) rupture without signs of knee synovitis. (C, D) Intraoperative ﬁndings.
(E) Immunostaining with anti-vimentin antibody that shows connective tissue, ﬁbroblastic cells, and multinucleated giant cells around the
polyethylene terephthalate (PET) ﬁbers. (F) Masson’s trichrome stain that shows connective tissue, ﬁbroblastic cells, and multinucleated giant
cells around the PET ﬁbers.
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The ﬁrst clinical report on the use of LARS in ACL recon-
struction was made by Dericks in 1995.15 He reported
encouraging results in 220 cases with a mean follow-up of
2.5 years, with no cases of knee synovitis.
In a previous work published in 2013, we made a litera-
ture review of all the papers that reported clinical results of
the LARS ligament for knee ligament reconstruction, search-
ing in four different databases (Pubmed, Scopus, Embase, and
Google Scholar).9 We found 35 papers for a total number of
1,245 cases with a follow-up ranging from 3 months to
9 years. We focused our attention on the number of graft
ruptures and the number of cases of knee synovitis that were
complications historically related to the use of artiﬁcial
ligaments. We recorded 12 graft ruptures (0.96%) and only
3 cases of knee synovitis (0.24%).9
These data are conﬁrmed by the results of this study and by
two recent systematic reviews.16,17 Anderson et al16 reported
comparable outcomes between the use of LARS ligament and
the use of autografts after a medium-term follow-up. Batty
et al17 compared the LARS ligament and others artiﬁcial
ligaments (Leeds-Keio, Kennedy-LAD, Dacron, Gore-Tex, and
Trevira) in terms of complications and clinical results. The
authors reported the lowest cumulative rates of failure with
the LARS device (2.6% for ACL and 1% for posterior cruciate
ligament surgery). Rates of noninfective synovitis and effusion
ranged from0.2% for LARS to27.6% forGore-Tex. Revision rates
ranged from 2.6% for LARS to 11.8% for Trevira.
Although the LARS ligament has been used for ACL recon-
struction since the late 1990s, there are very few studies that
analyzed the long-term results and sometimes the reported
data are discordant.18–21 Cerulli et al18 reported the results
obtained with the use of LARS ligament in ACL reconstruction
in a groupof 25patients after 9 years of follow-up. The authors
reported satisfactory results in over 95% of the cases with no
cases of knee synovitis. Jia et al19 reported the results of 91
patients at 7-year follow-up. They reported a failure rate of
4.4%, and an overall complication rate of 2.2%with 86.6% of the
patients returning to their sports activities. Wang et al20
reported on 26 cases of ACL reconstruction with LARS after
a mean follow-up of 11.9 years. The authors reported a
complication rate of 28.6% with two cases of knee synovitis.
In this cases series, oneof thehighlighted causesofgraft failure
was the loosening of the ﬁxation system. Tiefenboeck et al21
reported a low rate of patient satisfaction (55.6%) and a high
rate of complications (56%) after a minimum follow-up of
10 years. Complications consisted of graft breakage during
sport activity in 3 cases, surgical site infection in 3 cases, and
residual knee instability in 4 cases. The authors did not report
cases of knee reactive synovitis.
Differences between this study and that by Tiefenboeck
et al21 might be related to the method of graft ﬁxation
method. As reported by Viateau et al,22 the LARS ligament
has a very poor capacity of osteointegration in the bone
tunnels. For this reason, ﬁxation should not be achievedwith
absorbable devices.
To overcome the problemof the LARS ligament’s osteointe-
gration, several authorsworked in thelast years to enhance the
biologic ﬁxation of the graft using nanotechnologies.23–26
Another importantwaytoreducetheriskof long-termfailure
and debris formation that can led to reactive knee synovitis is to
preserve theACL stumps, as suggested by Trieb et al.14 Preserva-
tion of the torn ligament reduces the friction stress on the LARS
ﬁbers at the level of the bone tunnels and between the ﬁbers
themselves and promotes ﬁbroblast ingrowth.
This study has some limitations, mainly related to its
retrospective design. Moreover, the sample size is small
and all the patients were enrolled at the same hospital and
operated by the same surgeon. Finally, no baseline outcome
measures were available and therefore no data analysis on
improvement of baseline conditions was possible.
In conclusion, even if the long-term results of the use of
LARS are encouraging, the use of autologous grafts remain
the gold standard in ACL reconstruction, especially in young
people. LARS ligament can be considered a suitable option for
ACL reconstruction in carefully selected cases, especially for
older patients needing a fast functional recovery.
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